Document Detail


Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction.
MedLine Citation:
PMID:  20350645     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Telomeres shorten and aggregate with cellular senescence and oxidative stress. Telomerase and its catalytic component human telomerase reverse-transcriptase regulate telomere length. The pathogenesis of preeclampsia and intrauterine growth restriction involves hypoxic stress. We aimed to assess telomere length in trophoblasts from pregnancies with those complications. STUDY DESIGN: Placental specimens from 4 groups of patients were studied: severe preeclampsia, intrauterine growth restriction, preeclampsia combined with intrauterine growth restriction, and uncomplicated (control). Telomere length and human telomerase reverse-transcriptase expression were assessed by using quantitative fluorescence-in-situ protocol and immunohistochemistry. RESULTS: Telomere length was significantly lower in preeclampsia, intrauterine growth restriction, and preeclampsia plus intrauterine growth restriction placentas. More aggregates were found in preeclampsia, but not in intrauterine growth restriction placentas. Human telomerase reverse-transcriptase was significantly higher in the controls compared with the other groups. CONCLUSION: Telomeres are shorter in placentas from preeclampsia and intrauterine growth restriction pregnancies. Increased telomere aggregate formation in preeclampsia but not in intrauterine growth restriction pregnancies, implies different placental stress-related mechanisms in preeclampsia with or without intrauterine growth restriction.
Authors:
Tal Biron-Shental; Rivka Sukenik-Halevy; Yudith Sharon; Lilach Goldberg-Bittman; Dvora Kidron; Moshe D Fejgin; Aliza Amiel
Related Documents :
17962335 - The role of oxygen in prenatal growth: studies in the chick embryo.
3940335 - Early fetal growth retardation: obstetric background and recurrence rate.
22321195 - Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a ra...
2508475 - Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by...
13932025 - Gynecological aspects of obstetrical delivery.
3766625 - Intrapartum assessment of fetal well-being: a comparison of fetal acoustic stimulation ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  202     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-04-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  381.e1-7     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Affiliation:
Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biopsy
Cell Aging / genetics*
Female
Fetal Growth Retardation / genetics*,  metabolism,  pathology
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Oxidative Stress
Placenta / pathology,  physiopathology
Placenta Diseases / genetics*,  metabolism,  pathology
Pre-Eclampsia / genetics*,  metabolism,  pathology
Pregnancy
Pregnancy Trimester, Third
Telomerase / genetics,  metabolism
Telomere / metabolism,  pathology*
Chemical
Reg. No./Substance:
EC 2.7.7.49/Telomerase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Maternal and fetal oxidative stress and intrapartum term fever.
Next Document:  Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and ...